Pyrazinamide Tablets — Class II drug recall D-0568-2022
Terminated recall by ANI Pharmaceuticals, Inc., reported 2022-02-23, distributed nationwide. cGMP Deviations
| Recall number | D-0568-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | ANI Pharmaceuticals, Inc., Baudette, MN, United States |
| Recall initiated | 2022-02-15 |
| Classified | 2022-02-17 |
| Reported by FDA | 2022-02-23 |
| Terminated | 2022-10-25 |
| Distributed | Nationwide (US) |
| Quantity | 5,477 bottles |
| Reason classes | cgmp |
| NDC | 67253-0660-10 |
| Lot numbers | 19B064A |
| Expiration dates | 2022-03 |
Product
Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.
Reason for recall
cGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0568-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.